VitelleX Overview
- Year Founded
-
2025
- Status
-
Private
- Latest Deal Type
-
Early Stage VC
- Investors
-
1
VitelleX General Information
Description
Developer of a regenerative cell-manufacturing technology platform designed to industrialize donor-independent human tissue production. The company applies principles of early human development to create controlled 3D multicellular systems that generate stable, expandable cell types for regenerative medicine, enabling healthcare and life sciences markets to access reliable, scalable cell and tissue production.
Contact Information
Website
www.vitellex.comCorporate Office
- Oxfordlaan 55
- 6229 EV Maastricht
- Netherlands
Corporate Office
- Oxfordlaan 55
- 6229 EV Maastricht
- Netherlands
VitelleX Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Early Stage VC | 01-Dec-2025 | Completed | Startup |
VitelleX Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Particon | PE/Buyout | Minority |
VitelleX FAQs
-
When was VitelleX founded?
VitelleX was founded in 2025.
-
Where is VitelleX headquartered?
VitelleX is headquartered in Maastricht, Netherlands.
-
What industry is VitelleX in?
VitelleX’s primary industry is Biotechnology.
-
Is VitelleX a private or public company?
VitelleX is a Private company.
-
What is VitelleX’s current revenue?
The current revenue for VitelleX is .
-
Who are VitelleX’s investors?
Particon has invested in VitelleX.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process